A real-time and high-throughput neutralization test based on SARS-CoV-2 pseudovirus containing monomeric infrared fluorescent protein as reporter

References

• Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270–273.
   PubMed Web of Science ®Google Scholar
• Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727–733.
   PubMed Web of Science ®Google Scholar
• Masters PS, Coronaviridae PS, Knipe DM, et al. eds. Fields virology. 6th ed. Philadelphia (PA): Lippincott William & Wilkins; 2013. p. 747–794.
   Google Scholar
• V'kovski P, Kratzel A, Steiner S, et al. Coronavirus biology and replication: implications for SARS-CoV-2. Nat Rev Microbiol. 2020;28:1–16.
   Google Scholar
• Wrapp D, Wang N, Corbett KS, et al. Cryo-em structure of the 2019-ncov spike in the prefusion conformation. Science. 2020;367:1260–1263.
   PubMed Web of Science ®Google Scholar
• Walls AC, Park YJ, Tortorici MA, et al. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020;181:281–292.
   PubMed Web of Science ®Google Scholar
• Belouzard S, Chu VC, Whittaker GR. Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites. Proc Natl Acad Sci USA. 2009;106:5871–5876.
   PubMed Web of Science ®Google Scholar
• Coutard B, Valle C, de Lamballerie X, et al. The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antiviral Res. 2020;176:104742.
   PubMed Web of Science ®Google Scholar
• Hoffmann M, Kleine-Weber H, Pöhlmann S. A multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells. Mol Cell. 2020;78:779–784.
   PubMed Web of Science ®Google Scholar
• Shang J, Wan Y, Luo C, et al. Cell entry mechanisms of SARS-CoV-2. Proc Natl Acad Sci USA. 2020;117:11727–11734.
   PubMed Web of Science ®Google Scholar
• Korber B, Fischer WM, Gnanakaran S, et al. Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus. Cell. 2020;182:812–827.
   PubMed Web of Science ®Google Scholar
• CDC. Interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19). Atlanta (GA): US Department of Health and Human Services, CDC; 2020. https://www.cdc.gov/coronavirus/2019-nCoV/lab/lab-biosafety-guidelines.html#guidance.
   Google Scholar
• Crawford KHD, Eguia R, Dingens AS, et al. Protocol and reagents for pseudotyping lentiviral particles with SARS-CoV-2 spike protein for neutralization assays. Viruses. 2020;12(5):513.
   PubMed Web of Science ®Google Scholar
• Ou X, Liu Y, Lei X, et al. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat Commun. 2020;11(1):1620.
   PubMed Web of Science ®Google Scholar
• Schmidt F, Weisblum Y, Muecksch F, et al. Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses. J Exp Med. 2020;217:e20201181.
   PubMed Web of Science ®Google Scholar
• Zhang L, Jackson CB, Mou H, et al. SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity. Nat Commun. 2020;11(1):6013.
   PubMed Web of Science ®Google Scholar
• Berger F, Paulmurugan R, Bhaumik S, et al. Uptake kinetics and biodistribution of 14C-D-luciferin–a radiolabeled substrate for the firefly luciferase catalyzed bioluminescence reaction: impact on bioluminescence based reporter gene imaging. Eur J Nucl Med Mol Imaging. 2008;35:2275–2285.
   Web of Science ®Google Scholar
• Hock AK, Lee P, Maddocks OD, et al. Irfp is a sensitive marker for cell number and tumor growth in high-throughput systems. Cell Cycle. 2014;13:220–226.
   PubMed Web of Science ®Google Scholar
• Monici M. Cell and tissue autofluorescence research and diagnostic applications. Biotechnol Annu Rev. 2005;11:227–256.
   PubMedGoogle Scholar
• Teuscher AC, Ewald CY. Overcoming autofluorescence to assess gfp expression during normal physiology and aging in. Bio Protoc. 2018;8:e2940.
   Google Scholar
• Filonov GS, Piatkevich KD, Ting LM, et al. Bright and stable near-infrared fluorescent protein for in vivo imaging. Nat Biotechnol. 2011;29:757–761.
   PubMed Web of Science ®Google Scholar
• Shcherbakova DM, Verkhusha VV. Near-infrared fluorescent proteins for multicolor in vivo imaging. Nat Methods. 2013;10:751–754.
   PubMed Web of Science ®Google Scholar
• Zhang HL, Dong HL, Zhang YN, et al. Visualization of chikungunya virus infection. Emerg Microbes Infect. 2019;8:1574–1583.
   PubMed Web of Science ®Google Scholar
• Matlashov ME, Shcherbakova DM, Alvelid J, et al. A set of monomeric near-infrared fluorescent proteins for multicolor imaging across scales. Nat Commun. 2020;11(1):239.
   PubMed Web of Science ®Google Scholar
• Yu J, Tostanoski LH, Peter L, et al. DNA vaccine protection against SARS-CoV-2 in rhesus macaques. Science. 2020;369:806–811.
   PubMed Web of Science ®Google Scholar
• McMahan K, Yu J, Mercado NB, et al. Nature. 2020, Dec 4. https://doi.org/https://doi.org/10.1038/s41586-020-03041-6. Online ahead of print.
   Google Scholar
• Addetia A, Crawford KHD, Dingens A, et al. Neutralizing antibodies correlate with protection from SARS-CoV-2 in humans during a fishery vessel outbreak with a high attack rate. J Clin Microbiol. 2020;58:e02107–20.
   PubMed Web of Science ®Google Scholar
• Garcia-Beltran WF, Lam EC, Astudillo MG, et al. COVID-19-neutralizing antibodies predict disease severity and survival. Cell. 2021;184:476–488.
   PubMed Web of Science ®Google Scholar
• CDC. Emerging SARS-CoV-2 variants, updated Jan. 28, 2021. Atlanta (GA): US Department of Health and Human Services, CDC; 2020.https://www.cdc.gov/coronavirus/2019-ncov/more/science-and-research/scientific-brief-emerging-variants.html.
   Google Scholar
• du Plessis L, McCrone JT, Zarebski AE, et al. Establishment and lineage dynamics of the SARS-CoV-2 epidemic in the UK. Science. 2021;371:708–712.
   PubMed Web of Science ®Google Scholar
• Tegally H, Wilkinson E, Lessells RJ, et al. Sixteen novel lineages of SARS-CoV-2 in South Africa. Nat Med. 2021;27(3):440–446.
   PubMed Web of Science ®Google Scholar
• Connor RI, Chen BK, Choe S, et al. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology. 1995;206:935–944.
   PubMed Web of Science ®Google Scholar
• Hu HP, Hsieh SC, King CC, et al. Characterization of retrovirus-based reporter viruses pseudotyped with the precursor membrane and envelope glycoproteins of four serotypes of dengue viruses. Virology. 2007;368:376–387.
   Web of Science ®Google Scholar
• Rose JK, Welch WJ, Sefton BM, et al. Vesicular stomatitis virus glycoprotein is anchored in the viral membrane by a hydrophobic domain near the cooh terminus. Proc Natl Acad Sci USA. 1980;77:3884–3888.
   PubMed Web of Science ®Google Scholar
• Sabo Y, de Los Santos K, Goff SP. Iqgap1 negatively regulates HIV-1 gag trafficking and virion production. Cell Rep. 2020;30:4065–4081.
   Web of Science ®Google Scholar
• Hsieh SC, Wu YC, Zou G, et al. Highly conserved residues in the helical domain of dengue virus type 1 precursor membrane protein are involved in assembly, precursor membrane (prm) protein cleavage, and entry. J Biol Chem. 2014;289:33149–33160.
   PubMed Web of Science ®Google Scholar
• Simmons G, Reeves JD, Rennekamp AJ, et al. Characterization of severe acute respiratory syndrome-associated coronavirus (sars-cov) spike glycoprotein-mediated viral entry. Proc Natl Acad Sci USA. 2004;101:4240–4245.
   PubMed Web of Science ®Google Scholar
• Tsai WY, Chen HL, Tsai JJ, et al. Potent neutralizing human monoclonal antibodies preferentially target mature dengue virus particles: implication for novel strategy for dengue vaccine. J Virol. 2018;92:e01992–17.
   Web of Science ®Google Scholar
• Lee WT, Girardin RC, Dupuis AP, et al. Neutralizing antibody responses in COVID-19 convalescent sera. J Infect Dis. 2021;223:47–55.
   Web of Science ®Google Scholar
• Herrera BB, Tsai WY, Brites C, et al. T cell responses to nonstructural protein 3 distinguish infections by dengue and zika viruses. mBio. 2018;9:e00755–18.
   Web of Science ®Google Scholar
• Namekar M, Kumar M, O’Connell M, et al. Effect of serum heat-inactivation and dilution on detection of anti-WNV antibodies in mice by West Nile virus E-protein microsphere immunoassay. PLoS One. 2012;7:e45851.
   PubMed Web of Science ®Google Scholar
• Tan CW, Chia WN, Qin X, et al. A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction. Nat Biotechnol. 2020;38:1073–1078.
   PubMed Web of Science ®Google Scholar
• Barnes CO, West AP Jr, Huey-Tubman KE, et al. Structures of human antibodies bound to SARS-CoV-2 spike reveal common epitopes and recurrent features of antibodies. Cell. 2020;182:828-842.
   PubMed Web of Science ®Google Scholar
• Liu L, Wang P, Nair MS, et al. Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike. Nature. 2020;584:450–456.
   PubMed Web of Science ®Google Scholar
• Zost SJ, Gilchuk P, Case JB, et al. Potently neutralizing and protective human antibodies against SARS-CoV-2. Nature. 2020;584:443–449.
   PubMed Web of Science ®Google Scholar
• Peng P, Hu J, Deng HJ, et al. Changes in the humoral immunity response in SARS-CoV-2 convalescent patients over 8 months. Cell Mol Immunol. 2021;18:490–491.
   PubMed Web of Science ®Google Scholar
• Weissman D, Alameh MG, de Silva T, et al. D614g spike mutation increases SARS CoV-2 susceptibility to neutralization. Cell Host Microbe Cell Host Microbe. 2021;29:23–31.
   PubMed Web of Science ®Google Scholar